全文获取类型
收费全文 | 15796篇 |
免费 | 1359篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 585篇 |
妇产科学 | 363篇 |
基础医学 | 2079篇 |
口腔科学 | 402篇 |
临床医学 | 1983篇 |
内科学 | 3187篇 |
皮肤病学 | 148篇 |
神经病学 | 1676篇 |
特种医学 | 355篇 |
外科学 | 1543篇 |
综合类 | 215篇 |
一般理论 | 27篇 |
预防医学 | 2198篇 |
眼科学 | 176篇 |
药学 | 868篇 |
中国医学 | 31篇 |
肿瘤学 | 1258篇 |
出版年
2023年 | 73篇 |
2022年 | 143篇 |
2021年 | 336篇 |
2020年 | 197篇 |
2019年 | 324篇 |
2018年 | 372篇 |
2017年 | 261篇 |
2016年 | 287篇 |
2015年 | 308篇 |
2014年 | 454篇 |
2013年 | 669篇 |
2012年 | 889篇 |
2011年 | 980篇 |
2010年 | 548篇 |
2009年 | 474篇 |
2008年 | 967篇 |
2007年 | 942篇 |
2006年 | 868篇 |
2005年 | 926篇 |
2004年 | 882篇 |
2003年 | 811篇 |
2002年 | 779篇 |
2001年 | 290篇 |
2000年 | 266篇 |
1999年 | 293篇 |
1998年 | 191篇 |
1997年 | 163篇 |
1996年 | 151篇 |
1995年 | 153篇 |
1994年 | 127篇 |
1993年 | 96篇 |
1992年 | 224篇 |
1991年 | 223篇 |
1990年 | 207篇 |
1989年 | 206篇 |
1988年 | 184篇 |
1987年 | 183篇 |
1986年 | 151篇 |
1985年 | 159篇 |
1984年 | 120篇 |
1983年 | 136篇 |
1982年 | 117篇 |
1981年 | 108篇 |
1980年 | 93篇 |
1979年 | 82篇 |
1978年 | 96篇 |
1977年 | 58篇 |
1974年 | 40篇 |
1972年 | 53篇 |
1971年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Mark S. Wallace Steven G. Charapata Robert Fisher Michael Byas‐Smith Peter S. Staats Martha Mayo Dawn McGuire David Ellis 《Neuromodulation》2006,9(2):75-86
Objective. The safety and efficacy of intrathecal (IT) ziconotide was studied in a randomized, double‐blind, placebo‐controlled trial. Materials and Methods. Patients (169 ziconotide, 86 placebo) with severe chronic nonmalignant pain unresponsive to conventional therapy and a visual analog scale of pain intensity (VASPI score) ≥ 50 mm were treated over a 6‐day period in an inpatient hospital setting. Initial starting dose was 0.4 µg/hour and was titrated to analgesia or intolerance (maximum dose 7.0 µg/hour). The starting and maximum doses were reduced to 0.1 µg/hour and 2.4 µg/hour, respectively, due to adverse events (AEs). Results. The mean percent reduction in VASPI score from baseline was 31.2% and 6.0% for ziconotide‐ and placebo‐treated patients, respectively (p ≤ 0.001). During the initial titration phase, a significantly greater percentage of patients in the ziconotide group compared to the placebo group reported AEs, including abnormal gait, amblyopia, dizziness, nausea, nystagmus, pain, urinary retention, and vomiting. Conclusion. Ziconotide provided significant analgesia in patients for whom conventional therapy failed. However, there was a considerable incidence of ziconotide‐associated AEs due to the rapid titration and high doses administered. 相似文献
7.
Rammurti T Kamble George B Selby Martha Mims Mohamed A Kharfan-Dabaja Howard Ozer James N George 《Biology of blood and marrow transplantation》2006,12(5):506-510
Iron overload presenting as exacerbation of hepatic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation has not been previously described. We report 6 patients with established hepatic GVHD in whom iron overload (median serum ferritin, 7231 mug/dL; median transferrin saturation, 77%) resulting from a lifetime median of 20 units of packed red blood cell transfusions was manifested by worsening of liver function. Liver biopsies performed in 4 patients confirmed severe iron overload and also hepatic GVHD. Analysis for the C282Y and H63D hemochromatosis gene mutation was negative for the homozygous state in all 6 patients. Erythropoietin-assisted phlebotomy resulted in normalization of liver function at a median of 7 months and of serum ferritin at a median of 11 months. Immunosuppressive therapy was successfully tapered in all 4 patients who completed the phlebotomy program, and this supported the impression that iron overload, rather than GVHD, was the principal cause of liver dysfunction. At a median follow-up of 50 months (range, 18-76 months) from the transplantation and 25 months (range, 5-36 months) from ferritin normalization, all 4 patients require maintenance phlebotomy. We conclude that iron overload can mimic GVHD exacerbation, thus resulting in unnecessary continuation or intensification of immunosuppressive therapy for GVHD, and that maintenance phlebotomy is necessary after successful iron-reduction therapy. 相似文献
8.
Martha A. Warpehoski Paul J. Buscemi David C. Osborn Birdwell Finlayson Eugene P. Goldberg 《Calcified tissue international》1981,33(1):211-222
Summary The quantity of protein and carbohydrate comprising the matrix of calcium oxalate monohydrate (COM) renal stones was found
to decrease with distance from the surface of the stone. The average organic concentration of stones 3 to 30 mm in diameter
ranged from 5.7% at the surface to 2.7% at the core. This concentration gradient suggests matrix involvement in a “growth
front” on stone surfaces with migration of organic material from the “older” interior. The matrix distribution was not readily
correlated with density variations or with the presence of hydroxyapatite or calcium oxalate dihydrate. Surface matrix concentrations
were greater than amounts predicted by physical adsorption. Electron microscopy confirmed the presence of the organic-rich
surface layer and also suggested that increase in stone size occurs predominantly by crystal growth with microcrystal aggregates
as growth centers. 相似文献
9.
10.
A study was conducted to evaluate the efficacy of family history factors as screening criteria for childhood hypercholesterolemia. When they were seen for routine care at one of eight office practices, 1005 prepubertal children underwent random serum cholesterol determinations. Parental and grandparental histories of cardiovascular risk factors and atherosclerotic complications prior to 55 years of age were also obtained. Of the initial group, 274 children had total cholesterol levels greater than or equal to 175 mg/dL, and 175 of these children returned for retesting after an overnight fast. A total of 88 children were found to have low-density lipoprotein-cholesterol (LDL-C) values greater than or equal to 90th percentile for age and sex. Maternal and paternal histories of hypercholesterolemia were significantly associated with elevated LDL-C (odds ratio = 7.3 and 2.9, respectively), but had extremely low sensitivities (0.09, 0.15) despite modest positive predictive values (0.42, 0.22). Grandparental histories of sudden death, peripheral vascular disease, and gout were associated with elevated LDL-C, but sensitivities and positive predictive values for all of these factors were less than 0.22. Family history factors most commonly recommended as criteria for cholesterol screening in children did not identify half of all the children with elevated LDL-C and did not selectively identify the most severely affected children. Adding information concerning the presence of childhood obesity did not result in appreciable improvement in LDL-C detection beyond that achieved by family history factors alone. It was concluded that if thorough identification of young children with elevated LDL-C is desired, inclusive population screening rather than a family history-based strategy would be the most effective approach. 相似文献